Bioharvest Sciences Inc.: Form 40-F for the period ended Dec 31, 2025
Filed with the SEC on Mar 31, 2026 and accepted by EDGAR at Mar 31, 2026, 16:03 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $34.5m | us-gaap:Revenues |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $14.0m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $20.5m | ifrs-full:GrossProfit |
| Operating income | 12 months2025-01-01 to 2025-12-31 | −$5.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2025-01-01 to 2025-12-31 | −$76.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$11.1m | us-gaap:NetIncomeLoss |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | −$0.60 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | −$7.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $2.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-12-31 | $23.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $30.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $47.7m | ifrs-full:Assets |
| Current liabilities | At period end2025-12-31 | $7.7m | us-gaap:LiabilitiesCurrent |
| Short-term borrowings | At period end2025-12-31 | $149.0k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-12-31 | $25.4m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-12-31 | 22,666,842 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001376474-26-000257. Last ingested by Listed: Oct 29, 2026, 16:46 ET. Listed shows no prices and gives no investment advice.